Investors sold shares of Stericycle Inc. (NASDAQ:SRCL) on strength during trading hours on Tuesday. $12.10 million flowed into the stock on the tick-up and $49.76 million flowed out of the stock on the tick-down, for a money net flow of $37.66 million out of the stock. Of all stocks tracked, Stericycle had the 13th highest net out-flow for the day. Stericycle traded up $0.51 for the day and closed at $106.37

A number of analysts recently weighed in on SRCL shares. Imperial Capital upped their target price on shares of Stericycle from $95.00 to $115.00 and gave the stock an “in-line” rating in a research note on Friday, April 29th. Sterne Agee CRT started coverage on shares of Stericycle in a research note on Tuesday, March 22nd. They set a “buy” rating and a $151.00 target price on the stock. Oppenheimer Holdings Inc. restated a “hold” rating on shares of Stericycle in a research note on Saturday, April 30th. Stifel Nicolaus lowered shares of Stericycle from a “buy” rating to a “hold” rating in a research note on Friday, April 29th. Finally, Jefferies Group reiterated a “buy” rating and issued a $140.00 price target on shares of Stericycle in a research note on Tuesday, May 17th. One research analyst has rated the stock with a sell rating, ten have issued a hold rating and four have assigned a buy rating to the company. The stock has an average rating of “Hold” and a consensus price target of $124.50.

The stock has a market capitalization of $9.03 billion and a price-to-earnings ratio of 36.82. The firm’s 50 day moving average is $102.13 and its 200-day moving average is $111.00.

Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Thursday, April 28th. The company reported $1.11 EPS for the quarter, missing the consensus estimate of $1.15 by $0.04. The company earned $874.20 million during the quarter, compared to analysts’ expectations of $871.54 million. During the same quarter in the previous year, the business earned $1.08 earnings per share. The business’s quarterly revenue was up 31.8% compared to the same quarter last year. On average, analysts predict that Stericycle Inc. will post $4.93 EPS for the current fiscal year.

In related news, Director Mark C. Miller sold 34,835 shares of the business’s stock in a transaction that occurred on Friday, July 8th. The stock was sold at an average price of $104.52, for a total transaction of $3,640,954.20. Following the transaction, the director now directly owns 244,284 shares of the company’s stock, valued at approximately $25,532,563.68. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Mark C. Miller sold 25,000 shares of the business’s stock in a transaction that occurred on Wednesday, June 15th. The stock was sold at an average price of $101.12, for a total value of $2,528,000.00. Following the transaction, the director now directly owns 232,786 shares in the company, valued at $23,539,320.32. The disclosure for this sale can be found here.

Other institutional investors recently added to or reduced their stakes in the company. Vanguard Group Inc. increased its stake in Stericycle by 2.6% in the fourth quarter. Vanguard Group Inc. now owns 7,152,533 shares of the company’s stock valued at $862,596,000 after buying an additional 179,540 shares in the last quarter. Jennison Associates LLC increased its stake in Stericycle by 18.2% in the fourth quarter. Jennison Associates LLC now owns 1,549,196 shares of the company’s stock valued at $186,833,000 after buying an additional 238,349 shares in the last quarter. Ashmore Wealth Management LLC increased its stake in Stericycle by 185.0% in the fourth quarter. Ashmore Wealth Management LLC now owns 1,140,000 shares of the company’s stock valued at $137,484,000 after buying an additional 740,000 shares in the last quarter. Victory Capital Management Inc. increased its stake in Stericycle by 0.3% in the fourth quarter. Victory Capital Management Inc. now owns 714,514 shares of the company’s stock valued at $86,171,000 after buying an additional 2,044 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its stake in Stericycle by 89.4% in the fourth quarter. Robeco Institutional Asset Management B.V. now owns 333,122 shares of the company’s stock valued at $40,175,000 after buying an additional 157,263 shares in the last quarter.

Stericycle, Inc is engaged in the business of providing regulated and compliance solutions to healthcare and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, and a variety of training, consulting, recall/return, communication, and compliance services, which include training, consulting, inbound/outbound communications, data reporting, and other regulatory compliance services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.